Insulin pump therapy: a meta-analysis.

OBJECTIVE To conduct a meta-analysis of the metabolic and psychosocial impact of continuous subcutaneous insulin infusion (CSII) therapy on adults, adolescents, and children. RESEARCH DESIGN AND METHODS Studies were identified and data regarding study design, year of publication, sample size, patient's age, diabetes duration, and duration of CSII therapy were collected. Means and SDs for glycohemoglobin, blood glucose, insulin dosages, and body weight for CSII and comparison conditions were subjected to meta-analytic procedures. Data regarding pump complications and psychosocial functioning were reviewed descriptively. RESULTS A total of 52 studies, consisting of 1,547 patients, were included in the meta-analysis. Results indicate that CSII therapy is associated with significant improvements in glycemic control (decreased glycohemoglobin and mean blood glucose). A descriptive review of potential complications of CSII use (e.g., hypoglycemia, diabetic ketoacidosis [DKA], pump malfunction, and site infections) suggests a decreased frequency of hypoglycemic episodes but an increased frequency of DKA in studies published before 1993. CONCLUSIONS CSII therapy is associated with improved glycemic control compared with traditional insulin therapies (conventional therapy and multiple daily injections) and does not appear to be associated with significant adverse outcomes. Additional studies are needed to further examine the relative risks of CSII therapy, including the potential psychosocial impact of this technologically advanced therapy.

[1]  G. Albrecht,et al.  Results of treatment with continuous subcutaneous insulin infusion (CSII) in insulin-dependent (type I) diabetics. , 2009, Experimental and clinical endocrinology.

[2]  J. Huttunen,et al.  A crossover comparison of continuous insulin infusion and conventional injection treatment of type I diabetes. , 2009, Acta medica Scandinavica.

[3]  T. R. Taylor,et al.  Changes in cognitive and social functioning of diabetic patients following initiation of insulin infusion therapy. , 2007, Experimental aging research.

[4]  R. Heine,et al.  Insulin pump therapy: a meta-analysis: response to Weissberg-Benchell et al. , 2003, Diabetes care.

[5]  B. Zinman,et al.  Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection. , 2001, Diabetes care.

[6]  H. Chase,et al.  Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. , 2001, Pediatrics.

[7]  J. Tauber,et al.  Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes. , 2000, Diabetes care.

[8]  F. Ovalle,et al.  Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapy. , 2000, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[9]  A. L. Strickland,et al.  An outpatient technique for continuous subcutaneous insulin infusion in adolescents and young adults with IDDM. , 2000, Journal of the South Carolina Medical Association (1975).

[10]  R. Carney,et al.  Depression and poor glycemic control: a meta-analytic review of the literature. , 2000, Diabetes care.

[11]  F. Kaufman,et al.  Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes. , 2000, Diabetes care.

[12]  L. Crawford,et al.  Efficacy of insulin pump therapy: mealtime delivery is the key factor. , 2000, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[13]  W. Tamborlane,et al.  Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. , 1999, Diabetes care.

[14]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[15]  R. Heine,et al.  Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM , 1998, Diabetologia.

[16]  B. Guerci,et al.  Blood glucose control on Sunday in IDDM patients: intensified conventional insulin therapy versus continuous subcutaneous insulin infusion. , 1998, Diabetes research and clinical practice.

[17]  L. Vignati,et al.  Health-Related Quality-of-Life Results From Multinational Clinical Trials of Insulin Lispro: Assessing benefits of a new diabetes therapy , 1997, Diabetes Care.

[18]  E. Chantelau,et al.  Effect of patient-selected intensive insulin therapy on quality of life. , 1997, Patient education and counseling.

[19]  B. Anderson,et al.  Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus. , 1997, The Journal of pediatrics.

[20]  T. Kuno,et al.  Continuous subcutaneous insulin injection for self‐care of young patients with insulin‐dependent diabetes mellitus , 1996, Acta paediatrica Japonica : Overseas edition.

[21]  M. Dimatteo,et al.  The Role of Patient Participation in the Doctor Visit: Implications for adherence to diabetes care , 1996, Diabetes Care.

[22]  N. Tubiana-Rufi,et al.  Disparition des accidents hypoglycémiques sévères chez le très jeune enfant diabétique traité par pompe sous-cutanée , 1996 .

[23]  P. Davidson,et al.  Reduction in Severe Hypoglycemia With Long-Term Continuous Subcutaneous Insulin Infusion in Type I Diabetes , 1996, Diabetes Care.

[24]  G. Costin,et al.  Continuous subcutaneous insulin infusion (CSII) in children and adolescents with chronic poorly controlled type 1 diabetes mellitus. , 1995, Diabetes research and clinical practice.

[25]  J. Wylie-Rosett,et al.  Implementation of Treatment Protocols in the Diabetes Control and Complications Trial , 1995, Diabetes Care.

[26]  S. Johnson.  Health behavior and health status: concepts, methods, and applications. , 1994, Journal of pediatric psychology.

[27]  R. G. Cornell,et al.  A Prospective Study Identifying Risk Factors for Discontinuance of Insulin Pump Therapy , 1993, Diabetes Care.

[28]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[29]  P. Reichard,et al.  The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. , 1993, The New England journal of medicine.

[30]  E. Mallet,et al.  [Insulin therapy using a portable pump in children. Apropos of a pediatric experience]. , 1992, Annales de pediatrie.

[31]  K. DAHL‐JØRGENSEN,et al.  Continuous subcutaneous insulin infusion (CSII), multiple injections (MI) and conventional insulin therapy (CT) in self‐selecting insulin‐dependent diabetic patients. A comparison of metabolic control, acute complications and patient preferences , 1990, Journal of internal medicine.

[32]  C. de Beaufort,et al.  Psychological impact of continuous subcutaneous insulin infusion pump therapy in non-selected newly diagnosed insulin dependent (type 1) diabetic children: evaluation after two years of therapy. , 1990, Diabete & metabolisme.

[33]  J. Devlin,et al.  Diabetics treated with continuous subcutaneous insulin infusion pumps. , 1989, Irish medical journal.

[34]  I. Mühlhauser,et al.  Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for Type 1 (insulin-dependent) diabetes mellitus: a one centre experience , 1989, Diabetologia.

[35]  K. Hermansen,et al.  Effect of pump versus pen treatment on glycaemic control and kidney function in long-term uncomplicated insulin-dependent diabetes mellitus (IDDM). , 1989, Danish medical bulletin.

[36]  N. Saurbrey,et al.  Comparison of Continuous Subcutaneous Insulin Infusion with Multiple Insulin Injections Using the NovoPen , 1988, Diabetic medicine : a journal of the British Diabetic Association.

[37]  P. Czernichow,et al.  Feasibility of continuous subcutaneous insulin infusion in young diabetic patients. , 1988, Diabete & metabolisme.

[38]  K. Ullrich,et al.  [Continuous subcutaneous insulin infusion in the treatment of insulin-dependent diabetes mellitus]. , 1988, Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde.

[39]  R. Mecklenburg,et al.  Factors Related to Discontinuation of Continuous Subcutaneous Insulin-Infusion Therapy , 1988, Diabetes Care.

[40]  G. Cutter,et al.  Factors Associated with Discontinuation of Continuous Subcutaneous Insulin Infusion , 1988, The American journal of the medical sciences.

[41]  P. Haug,et al.  A self-controlled study of the effect of continuous subcutaneous insulin infusion on diabetic neuropathy , 1987, Journal of the Neurological Sciences.

[42]  S. Marshall,et al.  Continuous Subcutaneous Insulin Infusion Versus Injection Therapy: A Randomized Cross‐over Trial Under Usual Diabetic Clinic Conditions , 1987, Diabetic medicine : a journal of the British Diabetic Association.

[43]  H. Beck-Nielsen,et al.  Multiple insulin injections using a pen injector versus insulin pump treatment in young diabetic patients. , 1987, Diabetes research.

[44]  E. Schleicher,et al.  Sustained Normoglycemia and Remission Phase in Newly Diagnosed Type I Diabetic Subjects.Comparison Between Continuous Subcutaneous Insulin Infusion and Conventional Therapy During a One Year Follow-Up , 1987, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[45]  H. Bibergeil1,et al.  36 Months Continuous Subcutaneous Insulin Infusion (CSII) in Insulin Dependent Diabetes (IDDM) - Influence on Early Stages of Retinopathy, Nephropathy and Neuropathy - Psychological Analysis6)8) , 1987, Experimental and clinical endocrinology.

[46]  T. Deckert,et al.  Evaluation of insulin pump treatment under routine conditions. , 1987, Diabetes research and clinical practice.

[47]  J. Hülser,et al.  Effects of continuous subcutaneous insulin infusion and intensified conventional therapy on peripheral and autonomic nerve dysfunction. , 1987, The Journal of clinical endocrinology and metabolism.

[48]  P. Hamet,et al.  Effects of Continuous Subcutaneous Insulin Infusion Versus Multiple Injections on Insulin Receptors in Insulin-Dependent Diabetics , 1987, Diabetes Care.

[49]  T. Olsen,et al.  Diabetic retinopathy after 3 years' treatment with continuous subcutaneous insulin infusion (CSII) , 1987, Acta ophthalmologica.

[50]  J. Grimm,et al.  Lifestyle, metabolic control and social implications of pump therapy in 54 routine type I diabetic patients. , 1987, Diabete & metabolisme.

[51]  K. Dahl-Jørgensen,et al.  Increase in Insulin Antibodies During Continuous Subcutaneous Insulin Infusion and Multiple-Injection Therapy in Contrast to Conventional Treatment , 1987, Diabetes.

[52]  P. Brambilla,et al.  Risk of Ketosis During Intensive Insulin Therapy in Pre-School-Age Diabetic Children , 1987, Diabetes Care.

[53]  A. Boulton,et al.  Long term glycaemic control by alternative regimens in a feasibility study of continuous subcutaneous insulin infusion. , 1986, Diabetes research (Edinburgh, Scotland).

[54]  U. Smith,et al.  Altered Recognition of Hypoglycaemic Symptoms in Type I Diabetes during Intensified Control with Continuous Subcutaneous Insulin Infusion , 1986, Diabetic medicine : a journal of the British Diabetic Association.

[55]  V. Ja,et al.  Comparative study between the subcutaneous continuous insulin infusion pump and optimized conventional treatment. Effects at 6 months , 1986 .

[56]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.

[57]  S. Brink,et al.  Insulin pump treatment in insulin-dependent diabetes mellitus. Children, adolescents, and young adults. , 1986, JAMA.

[58]  K. Hermansen,et al.  The Effect of Six Months Continuous Subcutaneous Insulin Infusion on Kidney Function and Size in Insulin‐dependent Diabetics , 1986, Diabetic Medicine.

[59]  A. Boulton,et al.  Experience of Continuous Subcutaneous Insulin Infusion in the Outpatient Management of Diabetic Teenagers , 1986, Diabetic medicine : a journal of the British Diabetic Association.

[60]  A. Galatzer,et al.  Comparison of metabolic and psychological parameters during continuous subcutaneous insulin infusion and intensified conventional insulin treatment in type I diabetic patients. , 1985, Israel journal of medical sciences.

[61]  B. Blumenstein,et al.  Long-term metabolic control with insulin pump therapy. Report of experience with 127 patients. , 1985, The New England journal of medicine.

[62]  L. R. Reynolds,et al.  Long-term follow-up of diabetic patients using insulin infusion pumps. Considerations for future clinical application. , 1985, Archives of internal medicine.

[63]  R. Mecklenburg,et al.  Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients. , 1984, JAMA.

[64]  G. Sanborn,et al.  Effect of insulin infusion pump use on diabetic retinopathy. , 1984, Archives of ophthalmology.

[65]  P. Bougnères,et al.  Insulin pump therapy in young children with type 1 diabetes. , 1984, The Journal of pediatrics.

[66]  M. Charles,et al.  Personality and Family Profiles of Chronic Insulin-dependentDiabetic Patients Using Portable Insulin Infusion Pump Therapy: A Preliminary Investigation , 1984, Diabetes Care.

[67]  A. Schiffrin,et al.  Intensified Insulin Therapy in the Type I Diabetic Adolescent: A Controlled Trial , 1984, Diabetes Care.

[68]  A. Schiffrin,et al.  Feasibility of strict diabetes control in insulin-dependent diabetic adolescents. , 1983, The Journal of pediatrics.

[69]  S. Greene,et al.  Clinical application of insulin pumps in the management of insulin dependent diabetes. , 1983, Archives of disease in childhood.

[70]  R. Pujolborrell,et al.  [Insulin-dependent diabetes mellitus: subcutaneous insulin therapy with a portable infusion pump]. , 1983 .

[71]  T. Deckert,et al.  EFFECT OF 1 YEAR OF NEAR-NORMAL BLOOD GLUCOSE LEVELS ON RETINOPATHY IN INSULIN-DEPENDENT DIABETICS , 1983, The Lancet.

[72]  K. Alberti,et al.  A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSII. , 1982, Diabetes care.

[73]  P. Brunetti,et al.  Continuous subcutaneous insulin infusion treatment in insulin-dependent diabetic patients: a comparison with conventional optimized treatment in a long-term study. , 1982, Diabetes care.

[74]  R. Mecklenburg,et al.  Clinical use of the insulin infusion pump in 100 patients with type I diabetes. , 1982, New England Journal of Medicine.

[75]  J. Avruch,et al.  Intensive conventional and insulin pump therapies in adult type I diabetes. A crossover study. , 1982, Annals of internal medicine.

[76]  A. Lagreca,et al.  Psychological effects of intensification of diabetic control. , 1982, Diabetes Care.

[77]  J. Skyler,et al.  Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion. , 1982, The American journal of medicine.

[78]  A. Schiffrin,et al.  Comparison Between Continuous Subcutaneous Insulin Infusion and Multiple Injections of Insulin: A One-Year Prospective Study , 1982, Diabetes.

[79]  R. Bilous,et al.  Patient reactions to long-term outpatient treatment with continuous subcutaneous insulin infusion. , 1981, British medical journal.

[80]  N. Rodger,et al.  Continuous Subcutaneous Infusion of Insulin in the Management of Diabetes Mellitus , 1980, Diabetes.

[81]  W. Tamborlane,et al.  Treatment of Juvenile-onset Diabetes by Subcutaneous Infusion of Insulin with a Portable Pump , 1980, Diabetes Care.

[82]  W. Tamborlane,et al.  Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system. , 1980, The American journal of medicine.

[83]  H. Keen,et al.  LONG-TERM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN DIABETICS AT HOME , 1979, The Lancet.

[84]  J. N. Fisher,et al.  Evaluation of a Portable Insulin Infusion Pump for Outpatient Management of Brittle Diabetes , 1979, Diabetes Care.

[85]  W. Tamborlane,et al.  Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. , 1979, The New England journal of medicine.

[86]  J. Greenberg,et al.  ANTIBIOSIS IN SKIN FLORA , 1976, The Lancet.

[87]  A. M. Bold,et al.  SI UNITS , 1975, The Lancet.

[88]  J. Grizzle.  THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS. , 1965, Biometrics.

[89]  R. Wredling,et al.  Factors influencing the clinical outcome of continuous subcutaneous insulin infusion in routine practice. , 1993, Diabetes research and clinical practice.

[90]  L. Greca,et al.  Stress and coping in child health , 1992 .

[91]  R. G. Cornell,et al.  Quality of life activities associated with adherence to insulin infusion pump therapy in the treatment of insulin dependent diabetes mellitus. , 1989, Journal of clinical epidemiology.

[92]  H. Beck-Nielsen,et al.  Insulin pump treatment: effect on glucose homeostasis, metabolites, hormones, insulin antibodies and quality of life. , 1985, Diabetes research (Edinburgh, Scotland).

[93]  J. Skyler,et al.  A comparison of insulin regimens in insulin-dependent diabetes mellitus. , 1982, Diabetes care.